131 related articles for article (PubMed ID: 18782650)
1. Targeting solid tumors via T cell receptor complementarity-determining region 3delta in an engineered antibody.
Wang Z; Zhang T; Hu H; Zhang H; Yang Z; Cui L; He W
Cancer Lett; 2008 Dec; 272(2):242-52. PubMed ID: 18782650
[TBL] [Abstract][Full Text] [Related]
2. Gammadelta T cells recognize tumor cells via CDR3delta region.
Xu C; Zhang H; Hu H; He H; Wang Z; Xu Y; Chen H; Cao W; Zhang S; Cui L; Ba D; He W
Mol Immunol; 2007 Jan; 44(4):302-10. PubMed ID: 16650897
[TBL] [Abstract][Full Text] [Related]
3. The recognition of gammadelta TCR to protein antigen does not depend on the hydrophobic I97 residue of CDR3delta.
Xi X; Cui L; He W
Int Immunol; 2010 Apr; 22(4):299-306. PubMed ID: 20181655
[TBL] [Abstract][Full Text] [Related]
4. A novel antibody-like TCRγδ-Ig fusion protein exhibits antitumor activity against human ovarian carcinoma.
Zheng J; Guo Y; Ji X; Cui L; He W
Cancer Lett; 2013 Dec; 341(2):150-8. PubMed ID: 23920126
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.
Devaud C; Bilhere E; Loizon S; Pitard V; Behr C; Moreau JF; Dechanet-Merville J; Capone M
Cancer Res; 2009 May; 69(9):3971-8. PubMed ID: 19383918
[TBL] [Abstract][Full Text] [Related]
6. CDR3δ -grafted γ9δ2T cells mediate effective antitumor reactivity.
Zhao H; Xi X; Cui L; He W
Cell Mol Immunol; 2012 Mar; 9(2):147-54. PubMed ID: 21909128
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes.
Chen J; Niu H; He W; Ba D
Int Arch Allergy Immunol; 2001 Jul; 125(3):256-63. PubMed ID: 11490159
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding.
Sung C; Youle RJ; Dedrick RL
Cancer Res; 1990 Nov; 50(22):7382-92. PubMed ID: 2224866
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody construct.
Hammond SA; Lutterbuese R; Roff S; Lutterbuese P; Schlereth B; Bruckheimer E; Kinch MS; Coats S; Baeuerle PA; Kufer P; Kiener PA
Cancer Res; 2007 Apr; 67(8):3927-35. PubMed ID: 17440108
[TBL] [Abstract][Full Text] [Related]
11. CDR3 spectratyping identifies clonal expansion within T-cell subpopulations that demonstrate therapeutic antitumor activity.
Kim JA; Rao P; Graor H; Rothchild K; O'keefe C; Maciejewski JP
Surgery; 2004 Aug; 136(2):295-302. PubMed ID: 15300194
[TBL] [Abstract][Full Text] [Related]
12. Structure of a human gammadelta T-cell antigen receptor.
Allison TJ; Winter CC; Fournié JJ; Bonneville M; Garboczi DN
Nature; 2001 Jun; 411(6839):820-4. PubMed ID: 11459064
[TBL] [Abstract][Full Text] [Related]
13. Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model.
Foehr ED; Lorente G; Kuo J; Ram R; Nikolich K; Urfer R
Cancer Res; 2006 Feb; 66(4):2271-8. PubMed ID: 16489031
[TBL] [Abstract][Full Text] [Related]
14. Identification of human T cell receptor gammadelta-recognized epitopes/proteins via CDR3delta peptide-based immunobiochemical strategy.
Chen H; He X; Wang Z; Wu D; Zhang H; Xu C; He H; Cui L; Ba D; He W
J Biol Chem; 2008 May; 283(18):12528-37. PubMed ID: 18321859
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of gammadelta T cells in tumor immunology.
Kabelitz D; Wesch D; He W
Cancer Res; 2007 Jan; 67(1):5-8. PubMed ID: 17210676
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
17. Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22.
Adams EJ; Chien YH; Garcia KC
Science; 2005 Apr; 308(5719):227-31. PubMed ID: 15821084
[TBL] [Abstract][Full Text] [Related]
18. Antigen recognition determinants of gammadelta T cell receptors.
Shin S; El-Diwany R; Schaffert S; Adams EJ; Garcia KC; Pereira P; Chien YH
Science; 2005 Apr; 308(5719):252-5. PubMed ID: 15821090
[TBL] [Abstract][Full Text] [Related]
19. Depletion of gammadelta T cells exacerbates murine adriamycin nephropathy.
Wu H; Wang YM; Wang Y; Hu M; Zhang GY; Knight JF; Harris DC; Alexander SI
J Am Soc Nephrol; 2007 Apr; 18(4):1180-9. PubMed ID: 17329577
[TBL] [Abstract][Full Text] [Related]
20. Antigen specificity of gammadelta T cells depends primarily on the flanking sequences of CDR3delta.
Xi X; Guo Y; Chen H; Xu C; Zhang H; Hu H; Cui L; Ba D; He W
J Biol Chem; 2009 Oct; 284(40):27449-55. PubMed ID: 19666468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
